EXPEDITION-I: efficacy and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosis
2017 ◽
Vol 66
(1)
◽
pp. S3-S4
◽
Keyword(s):
2018 ◽
Vol 53
(12)
◽
pp. 1276-1284
◽
2019 ◽
Vol 54
(8)
◽
pp. 742-751
◽
2013 ◽
Vol 20
(Suppl 1)
◽
pp. A106.2-A106
Keyword(s):
2017 ◽
Vol 55
◽
pp. 56-71
◽
Keyword(s):
2013 ◽
Vol 52
(6)
◽
pp. 653-660
◽